Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) TAI

Currency In TWD

AD

Valuation

Market Cap1.36B
Enterprise Value1.95B
P/E Ratio-13.11
PEG Ratio1.84
Price/Sales Ratio3
Price/Book Ratio0.66
Enterprise/Revenue3.53
Enterprise/EBITDA-58.04

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.16
Operating Margin-0.23
AD

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.05

Income Statement

Revenue804.88M
Revenue/Share17.62
Gross Profit-8.86M
EBITDA-128.19M
Net Income-243.85M
Diluted EPS-4.39

Balance Sheet

Total Cash286.49M
Total Cash/Share5.19
Total Debt804.58M
Total Debt/Equity0.25
Current Ratio3.02
Book Value Per Share57.56

Price History

52-Week Change37.32
52-Week High44.75
52-Week Low24.2
Moving Average 50 Days37.17
Moving Average 200 Days29.08

Statistics

Average Volume591,490
Shares Outstanding76.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.51
Payout Ratio-0.09
Last Split FactorN/A
Last Split DateN/A
AD